Menu
GeneBe

rs61750239

Variant summary

Our verdict is Uncertain significance. Variant got -2 ACMG points: 2P and 4B. PP3PP4BS2

This summary comes from the ClinGen Evidence Repository: The p.Arg268Trp variant in MECP2 (NM_004992.3) is observed in at least 2 unaffected individuals (PMID 12750821, internal database - Invitae) (BS2). The p.Arg268Trp variant in MECP2 has been reported in an individual with a clinical phenotype suggestive of Rett syndrome (PMID 18842453) (PP4). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). The p.Arg268Trp variant in MECP2 is present in gnomAD v2.1.1 at a frequency of 0.0009792% (no criteria met). In summary, the p.Arg268Trp variant in MECP2 is classified as a Variant of Uncertain Significance based on the ACMG/AMP criteria (BS2, PP3, PP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA233007/MONDO:0010726/016

Frequency

Genomes: đť‘“ 0.000036 ( 0 hom., 1 hem., cov: 23)
Exomes đť‘“: 0.000024 ( 0 hom. 3 hem. )

Consequence

MECP2
NM_001110792.2 missense

Scores

11
5
1

Clinical Significance

Uncertain significance reviewed by expert panel U:4B:2O:1

Conservation

PhyloP100: 5.13
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got -2 ACMG points.

PP3
PP4
BS2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.838C>T p.Arg280Trp missense_variant 3/3 ENST00000453960.7
MECP2NM_004992.4 linkuse as main transcriptc.802C>T p.Arg268Trp missense_variant 4/4 ENST00000303391.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MECP2ENST00000453960.7 linkuse as main transcriptc.838C>T p.Arg280Trp missense_variant 3/31 NM_001110792.2 P51608-2
MECP2ENST00000303391.11 linkuse as main transcriptc.802C>T p.Arg268Trp missense_variant 4/41 NM_004992.4 P1P51608-1

Frequencies

GnomAD3 genomes
AF:
0.0000355
AC:
4
AN:
112533
Hom.:
0
Cov.:
23
AF XY:
0.0000288
AC XY:
1
AN XY:
34697
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000930
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000564
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000548
AC:
1
AN:
182455
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67367
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000237
AC:
26
AN:
1098176
Hom.:
0
Cov.:
35
AF XY:
0.00000825
AC XY:
3
AN XY:
363548
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000369
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000285
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000355
AC:
4
AN:
112533
Hom.:
0
Cov.:
23
AF XY:
0.0000288
AC XY:
1
AN XY:
34697
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.0000930
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000564
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000526
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4Benign:2Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:1Other:1
not provided, no classification providedliterature onlyRettBASE-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxApr 25, 2019Reported as pathogenic [in ClinVar/in a well-curated database/through personal communication] but additional evidence is not available [ref]; Reported as pathogenic [in ClinVar/in a well-curated database/through personal communication] but additional evidence is not available [ref]; This variant is associated with the following publications: (PMID: 11469283, 18842453, 12750821) -
Severe neonatal-onset encephalopathy with microcephaly Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 26, 2024This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 268 of the MECP2 protein (p.Arg268Trp). This variant is present in population databases (rs61750239, gnomAD 0.002%). This missense change has been observed in individual(s) with X-linked intellectual disability and/or Rett syndrome (PMID: 11469283, 12750821, 18842453). ClinVar contains an entry for this variant (Variation ID: 143700). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on MECP2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Rett syndrome Uncertain:1
Uncertain significance, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelOct 28, 2021The p.Arg268Trp variant in MECP2 (NM_004992.3) is observed in at least 2 unaffected individuals (PMID 12750821, internal database - Invitae) (BS2). The p.Arg268Trp variant in MECP2 has been reported in an individual with a clinical phenotype suggestive of Rett syndrome (PMID 18842453) (PP4). Computational prediction analysis tools suggests a deleterious impact; however, this information does not predict clinical significance on its own (PP3). The p.Arg268Trp variant in MECP2 is present in gnomAD v2.1.1 at a frequency of 0.0009792% (no criteria met). In summary, the p.Arg268Trp variant in MECP2 is classified as a Variant of Uncertain Significance based on the ACMG/AMP criteria (BS2, PP3, PP4). -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 30, 2024Unlikely to be causative of Rett syndrome (XLD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Rett syndrome;C0796222:X-linked intellectual disability-psychosis-macroorchidism syndrome;C1845336:Autism, susceptibility to, X-linked 3;C1846058:Syndromic X-linked intellectual disability Lubs type;C1968556:Severe neonatal-onset encephalopathy with microcephaly Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
X-linked intellectual disability-psychosis-macroorchidism syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingGénétique des Maladies du Développement, Hospices Civils de Lyon-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.57
D
BayesDel_noAF
Pathogenic
0.58
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.82
D;.;T
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;D;D
M_CAP
Pathogenic
0.93
D
MetaRNN
Pathogenic
0.85
D;D;D
MetaSVM
Uncertain
0.71
D
MutationAssessor
Uncertain
2.3
M;.;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-3.2
D;D;.
REVEL
Pathogenic
0.83
Sift
Pathogenic
0.0
D;D;.
Sift4G
Uncertain
0.034
D;T;D
Polyphen
1.0
D;D;.
Vest4
0.66
MVP
1.0
ClinPred
0.92
D
GERP RS
4.7
Varity_R
0.62
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61750239; hg19: chrX-153296477; COSMIC: COSV57657805; COSMIC: COSV57657805; API